{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T05:31:35Z","timestamp":1791869495778,"version":"4.3.4"},"reference-count":28,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,6,13]],"date-time":"2022-06-13T00:00:00Z","timestamp":1655078400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01HL143881"],"award-info":[{"award-number":["R01HL143881"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000968","name":"American Heart Association","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000968","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jacc.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["JACC: Basic to Translational Science"],"published-print":{"date-parts":[[2022,11]]},"DOI":"10.1016\/j.jacbts.2022.06.001","type":"journal-article","created":{"date-parts":[[2022,10,12]],"date-time":"2022-10-12T20:19:11Z","timestamp":1665605951000},"page":"1143-1157","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":23,"title":["Therapeutic CCR2 Blockade Prevents Inflammation and Alleviates Myxomatous Valve Disease in Marfan Syndrome"],"prefix":"10.1016","volume":"7","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5387-7760","authenticated-orcid":false,"given":"Na","family":"Xu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1444-7124","authenticated-orcid":false,"given":"Katherine E.","family":"Yutzey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jacbts.2022.06.001_bib1","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1016\/S0140-6736(16)00558-4","article-title":"Mitral valve disease \u2014 current management and future challenges","volume":"387","author":"Nishimura","year":"2016","journal-title":"Lancet"},{"key":"10.1016\/j.jacbts.2022.06.001_bib2","doi-asserted-by":"crossref","first-page":"71","DOI":"10.4330\/wjc.v11.i2.71","article-title":"Heart valve disease in elderly","volume":"11","author":"Rostagno","year":"2019","journal-title":"World J Cardiol"},{"key":"10.1016\/j.jacbts.2022.06.001_bib3","article-title":"Mitral valve prolapse and its motley crew-syndromic prevalence, pathophysiology, and progression of a common heart condition","volume":"10","author":"Morningstar","year":"2021","journal-title":"J\u00a0Am Heart Assoc"},{"key":"10.1016\/j.jacbts.2022.06.001_bib4","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1038\/nrcardio.2015.161","article-title":"Mitral valve disease \u2014 morphology and mechanisms","volume":"12","author":"Levine","year":"2015","journal-title":"Nat Rev Cardiol"},{"key":"10.1016\/j.jacbts.2022.06.001_bib5","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/S1054-8807(98)00021-0","article-title":"Correlation between clinical and histologic patterns of degenerative mitral valve insufficiency: a histomorphometric study of 130 excised segments","volume":"8","author":"Fornes","year":"1999","journal-title":"Cardiovasc Pathol"},{"key":"10.1016\/j.jacbts.2022.06.001_bib6","first-page":"200","article-title":"Increased infiltration of extra-cardiac cells in myxomatous valve disease","volume":"2","author":"Sauls","year":"2015","journal-title":"J\u00a0Cardiovasc Dev Dis"},{"key":"10.1016\/j.jacbts.2022.06.001_bib7","doi-asserted-by":"crossref","first-page":"1232","DOI":"10.1016\/j.jacc.2017.07.734","article-title":"Effect of losartan on mitral valve changes after myocardial infarction","volume":"70","author":"Bartko","year":"2017","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacbts.2022.06.001_bib8","doi-asserted-by":"crossref","first-page":"S189","DOI":"10.1161\/CIRCULATIONAHA.111.082610","article-title":"Modulation of transforming growth factor-beta signaling and extracellular matrix production in myxomatous mitral valves by angiotensin II receptor blockers","volume":"126","author":"Geirsson","year":"2012","journal-title":"Circulation"},{"key":"10.1016\/j.jacbts.2022.06.001_bib9","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1161\/CIRCULATIONAHA.119.042391","article-title":"Deficiency of circulating monocytes ameliorates the progression of myxomatous valve degeneration in Marfan syndrome","volume":"141","author":"Kim","year":"2020","journal-title":"Circulation"},{"key":"10.1016\/j.jacbts.2022.06.001_bib10","first-page":"230","article-title":"CCR2(+) monocyte-derived infiltrating macrophages are required for adverse cardiac remodeling during pressure overload","volume":"3","author":"Patel","year":"2018","journal-title":"J\u00a0Am Coll Cardiol Basic Trans Science"},{"key":"10.1016\/j.jacbts.2022.06.001_bib11","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.trsl.2017.10.001","article-title":"Cardiac macrophage biology in the steady-state heart, the aging heart, and following myocardial infarction","volume":"191","author":"Ma","year":"2018","journal-title":"Transl Res"},{"key":"10.1016\/j.jacbts.2022.06.001_bib12","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1161\/CIRCRESAHA.118.314030","article-title":"Molecular imaging visualizes recruitment of inflammatory monocytes and macrophages to the injured heart","volume":"124","author":"Heo","year":"2019","journal-title":"Circ Res"},{"key":"10.1016\/j.jacbts.2022.06.001_bib13","doi-asserted-by":"crossref","first-page":"E4661","DOI":"10.1073\/pnas.1720065115","article-title":"Distinct roles of resident and nonresident macrophages in nonischemic cardiomyopathy","volume":"115","author":"Liao","year":"2018","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jacbts.2022.06.001_bib14","doi-asserted-by":"crossref","first-page":"1478","DOI":"10.1093\/eurheartj\/ehu225","article-title":"Silencing of CCR2 in myocarditis","volume":"36","author":"Leuschner","year":"2015","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacbts.2022.06.001_bib15","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1161\/CIRCRESAHA.118.314028","article-title":"Tissue resident CCR2- and CCR2+ cardiac macrophages differentially orchestrate monocyte recruitment and fate specification following myocardial injury","volume":"124","author":"Bajpai","year":"2019","journal-title":"Circ Res"},{"key":"10.1016\/j.jacbts.2022.06.001_bib16","doi-asserted-by":"crossref","first-page":"2038","DOI":"10.1161\/CIRCULATIONAHA.112.000116","article-title":"Monocyte-directed RNAi targeting CCR2 improves infarct healing in atherosclerosis-prone mice","volume":"127","author":"Majmudar","year":"2013","journal-title":"Circulation"},{"key":"10.1016\/j.jacbts.2022.06.001_bib17","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1038\/nbt.1989","article-title":"Therapeutic siRNA silencing in inflammatory monocytes in mice","volume":"29","author":"Leuschner","year":"2011","journal-title":"Nat Biotechnol"},{"key":"10.1016\/j.jacbts.2022.06.001_bib18","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1172\/JCI200420641","article-title":"Evidence for a critical contribution of haploinsufficiency in the complex pathogenesis of Marfan syndrome","volume":"114","author":"Judge","year":"2004","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.jacbts.2022.06.001_bib19","doi-asserted-by":"crossref","first-page":"25562","DOI":"10.1074\/jbc.M000692200","article-title":"Identification of the binding site for a novel class of CCR2b chemokine receptor antagonists: binding to a common chemokine receptor motif within the helical bundle","volume":"275","author":"Mirzadegan","year":"2000","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.jacbts.2022.06.001_bib20","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1038\/ki.2010.263","article-title":"CCR2 antagonism improves insulin resistance, lipid metabolism, and diabetic nephropathy in type 2 diabetic mice","volume":"78","author":"Kang","year":"2010","journal-title":"Kidney Int"},{"key":"10.1016\/j.jacbts.2022.06.001_bib21","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.molimm.2019.02.014","article-title":"504393 inhibits M-MDSCs recruiting in immune microenvironment of bladder cancer after gemcitabine treatment","volume":"109","author":"Mu","year":"2019","journal-title":"Mol Immunol"},{"key":"10.1016\/j.jacbts.2022.06.001_bib22","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1111\/exd.14088","article-title":"Antifibrogenic effects of C-C chemokine receptor type 2 antagonist in a bleomycin-induced scleroderma model","volume":"30","author":"Ishikawa","year":"2021","journal-title":"Exp Dermatol"},{"key":"10.1016\/j.jacbts.2022.06.001_bib23","doi-asserted-by":"crossref","first-page":"D1398","DOI":"10.1093\/nar\/gkab953","article-title":"Therapeutic target database update 2022: facilitating drug discovery with enriched comparative data of targeted agents","volume":"50","author":"Zhou","year":"2022","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.jacbts.2022.06.001_bib24","first-page":"2506","article-title":"Innate and adaptive immunity: the understudied driving force of heart valve disease","volume":"117","author":"Bartoli-Leonard","year":"2021","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.jacbts.2022.06.001_bib25","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1093\/cvr\/cvw229","article-title":"Loss of Axin2 results in impaired heart valve maturation and subsequent myxomatous valve disease","volume":"113","author":"Hulin","year":"2017","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.jacbts.2022.06.001_bib26","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1093\/cvr\/cvs262","article-title":"Chemokine (C-C motif) receptor 2 mediates mast cell migration to abdominal aortic aneurysm lesions in mice","volume":"96","author":"Zhang","year":"2012","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.jacbts.2022.06.001_bib27","doi-asserted-by":"crossref","first-page":"1616","DOI":"10.1136\/heartjnl-2019-314879","article-title":"Calcification and extracellular matrix dysregulation in human postmortem and surgical aortic valves","volume":"105","author":"Gomez-Stallons","year":"2019","journal-title":"Heart"},{"key":"10.1016\/j.jacbts.2022.06.001_bib28","article-title":"Histopathological maladaptive changes in the explanted human mitral leaflets correlate with changes in echocardiographic leaflet morphology and the severity of ischemic mitral regurgitation","author":"Avila-Vanzzini","year":"2022","journal-title":"Eur Heart J Cardiovasc Imaging"}],"container-title":["JACC: Basic to Translational Science"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2452302X22002182?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2452302X22002182?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T00:25:41Z","timestamp":1762820741000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2452302X22002182"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11]]},"references-count":28,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2022,11]]}},"alternative-id":["S2452302X22002182"],"URL":"https:\/\/doi.org\/10.1016\/j.jacbts.2022.06.001","relation":{},"ISSN":["2452-302X"],"issn-type":[{"value":"2452-302X","type":"print"}],"subject":[],"published":{"date-parts":[[2022,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Therapeutic CCR2 Blockade Prevents Inflammation and Alleviates Myxomatous Valve Disease in Marfan Syndrome","name":"articletitle","label":"Article Title"},{"value":"JACC: Basic to Translational Science","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jacbts.2022.06.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Authors. Published by Elsevier on behalf of the American College of Cardiology Foundation.","name":"copyright","label":"Copyright"}]}}